The week in health tech, explained in plain English.Get the free newsletter →
October 14, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

By Healthcare Technology News ·

Walmart is removing the price tag on dozens of common drugs for its workforce. Starting in 2027, the retailer will make more than 250 medications available to employees at no cost, including insulin, inhalers and some GLP-1s, the company confirmed to Becker's Hospital Review on Oct. 13.

GLP-1 drugs were already covered for Walmart employees with Type 2 diabetes. The change makes them free, at $0, through a new prior authorization process. That distinction matters: the benefit targets diabetes treatment, not the broader and far costlier demand for GLP-1s as weight-loss drugs, which many large employers have been reluctant to cover.

Walmart's move reflects a growing tension for self-insured employers. GLP-1s like Ozempic and Wegovy drive strong clinical results but strain pharmacy budgets. By zeroing out cost-sharing on diabetes medications while gating access through prior authorization, Walmart is betting that improved adherence and chronic-disease control can offset spending over time.

Sources

More in Payers

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.

Payers

Academic Health Systems Are Underpricing Their Payer Contracts

ECG's managed care experts say academic health systems routinely undervalue their advanced services in payer contracts and must negotiate terms that reflect their true costs.

Why it matters: Academic health systems operate on thin margins, and payer contracts that ignore their higher costs threaten the research and safety-net care only they provide.

Payers

Why Insurers Want Agentic AI as Connective Tissue

Health insurers are looking to agentic AI to orchestrate their existing systems rather than buy more standalone tools, Healthcare Dive reports.

Why it matters: If agentic AI can connect fragmented payer systems, it could cut the administrative costs that make health insurance slow and expensive.